Search Within

Elisa De Stanchina

  1. "2013"
Formats
  1. Journal Article (7)
  2. Meeting Abstract (6)
Groups
  1. Department of Medicine (10)
  2. GSK Faculty (9)
  3. Center for Hematologic Malignancies (7)
  4. Sloan Kettering Institute Faculty (7)
  5. Solid Tumor Oncology Division (7)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (6)

More Groups

People
  1. Gary Schwartz (2)
  2. Gregory Carbonetti (2)
  3. Justin Cross (2)
  4. Kaitlyn Shank (2)
  5. Neal Rosen (2)
  6. Ross Levine (2)

More People

Years
  1. 2013 (13)
Publications
  1. Blood (3)
  2. Cancer Research (3)
  3. Cancer Cell (1)
  4. Cold Spring Harbor Protocols (1)
  5. Journal of Clinical Investigation (1)
  6. Journal of Nuclear Medicine (1)

More Publications

Publishers
  1. American Association for Cancer Research (4)
  2. American Society of Hematology (3)
  3. American Society for Clinical Investigation (1)
  4. Cell Press (1)
  5. Cold Spring Harbor Laboratory Press (1)
  6. Elsevier Science Inc. (1)

More Publishers

Results (13)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prevention of minimal residual disease in Ph+ ALL
    Meeting Abstract

    Appelmann, I.; DeStanchina, E.; Carbonetti, G.; Chen, C.; Lowe, S. W.; Sherr, C. J.
    Blood (2013)

    Fulltext@MSK | Save
  • Epigenetic profiling of leukemia stem cells in a model of TET2/FLT3-mutant AML
    Meeting Abstract

    Shih, A. H.; Jiang, Y.; Shank, K.; Pandey, S.; Viale, A.; Sun, Y.; Socci, N.; Robertson, A.; de Stanchina, E.; Hricik, T.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Improved efficacy of combination of JAK2 and Hedgehog inhibitors in myelofibrosis
    Meeting Abstract

    Bhagwat, N.; Keller, M. D.; Rampal, R. K.; Shank, K.; de Stanchina, E.; Rose, K.; Amakye, D.; Levine, R. L.
    Blood (2013)

    Fulltext@MSK | Save
  • Acquired resistance to rapamycin and mTOR kinase inhibitors is mediated by non-overlapping mutations in distinct sites in the mTOR protein
    Meeting Abstract

    Rodrik-Outmezguine, V.; Yao, Z.; Berger, M.; De Stanchina, E.; Klinowska, T.; Barratt, D.; Baselga, J.; Rosen, N.
    Cancer Research (2013)

    Fulltext@MSK | Save
  • MLN0128, an investigational selective TORC1/2 kinase inhibitor, demonstrates potent antitumor activity in preclinical models of soft tissue sarcoma
    Meeting Abstract

    Patwardhan, P.; Deraje Vasudeva, S.; Tap, W. D.; de Stanchina, E.; Schwartz, G. K.
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Feedback dependent suppression of mitogenic signaling and its effect on RAF inhibition in BRAFV600E melanomas
    Meeting Abstract

    Lito, P.; Pratilas, C.; Joseph, E.; Tadi, M.; Halilovic, E.; Zubrowski, M.; Huang, A.; de Stanchina, E.; Chandarlapaty, S.; Poulikakos, P.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Direct reversal of glucocorticoid resistance by AKT inhibition in acute lymphoblastic leukemia
    Journal Article

    Piovan, E.; Yu, J.; Tosello, V.; Herranz, D.; Ambesi-Impiombato, A.; DaSilva, A.; Sanchez-Martin, M.; Perez-Garcia, A.; Rigo, I.; Castillo, M.; more...
    Cancer Cell (2013)

    Fulltext@MSK | Save
  • Infrastructure needs for translational integration of mouse and human trials
    Journal Article

    Clohessy, J. G.; de Stanchina, E.
    Cold Spring Harbor Protocols (2013)

    Fulltext@MSK | Save
  • The IL-6/JAK/Stat3 feed-forward loop drives tumorigenesis and metastasis
    Journal Article

    Chang, Q.; Bournazou, E.; Sansone, P.; Berishaj, M.; Gao, S. P.; Daly, L.; Wels, J.; Theilen, T.; Granitto, S.; Zhang, X.; more...
    NeoPlasia (2013)

    Fulltext@MSK | Save
  • Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids
    Journal Article

    Kamphorst, J. J.; Cross, J. R.; Fan, J.; de Stanchina, E.; Mathew, R.; White, E. P.; Thompson, C. B.; Rabinowitz, J. D.
    Proceedings of the National Academy of Sciences of the United States of America (2013)

    Fulltext@MSK | Save